Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication UK00911800984 · Registered
| Application Number | UK00911800984 |
| Status | Registered |
| Owner | CSL Behring GmbH |
| Filed | 2013-05-08 |
| Registered | 2013-09-19 |
| Renewal Due | 2033-05-08 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. DEIXAR is currently a registered UK trademark, with renewal due on 2033-05-08. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations and substances; pharmaceutical preparations for the treatment of blood or bleeding disorders; blood products and products derived from blood; products derived from recombinant DNA technology; albumin blood proteins for therapeutic use; immunoglobulins, included in class 5; preparations for treatment of deficiencies of blood coagulation.
'DEIXAR' is a registered trademark on the UK IPO register, owned by CSL Behring GmbH. The application (UK00911800984) was filed on 8 May 2013 and registered on 19 September 2013. The registration is set to expire on 8 May 2033.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Venner Shipley LLP.
UK trademark UK00911800984 for the mark 'DEIXAR' in Class 5 is recorded on the UK IPO register as owned by CSL Behring GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00911800984 for the mark 'DEIXAR' as registered.
UK trademark UK00911800984 for the mark 'DEIXAR' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations and substances; pharmaceutical preparations for the treatment of blood or bleeding disorders; blood products and products derived from blood; products derived from recombinant DNA technology; albumin blood proteins for therapeutic use; immunoglobulins, included in class 5; prepar…
UK trademark UK00911800984 for the mark 'DEIXAR' was filed at the UK IPO on 8 May 2013 and registered on 19 September 2013.
UK trademark UK00911800984 for the mark 'DEIXAR' is currently recorded as valid until 8 May 2033, at which point it will need to be renewed with the UK IPO to remain in force.
Venner Shipley LLP is listed as the attorney / representative of record for UK trademark UK00911800984 for the mark 'DEIXAR' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.